Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Peppercorn

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Clinical Gastroenterology|April 30, 2004
The overlap of inflammatory bowel disease and diverticular diseaseMark A Peppercorn
Gastroenterology Clinics of North America|July 19, 2002
Inflammatory bowel disease. Medical therapy of specific clinical presentationsSubhas Banerjee, Mark A Peppercorn
Inflammatory Bowel Diseases|May 5, 2011
New genetic data support an association between celiac disease and inflammatory bowel diseaseGarrett Lawlor, Mark A Peppercorn
Therapeutic Advances in Gastroenterology|December 25, 2010
Ulcerative colitis: current treatment strategies and future prospectsSagar Garud, Mark A Peppercorn
World Journal of Gastroenterology|April 4, 2014
Immunosuppressive therapies for inflammatory bowel diseaseTalia Zenlea, Mark A Peppercorn
Clinical and Experimental Gastroenterology|June 23, 2011
Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's diseaseGlen A Doherty, Mark A Peppercorn
Lancet (London, England)|February 7, 2002
Ulcerative colitisRichard J Farrell, Mark A Peppercorn
Patient Preference and Adherence|November 26, 2009
Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamineDaniel B Zandman, Mark A Peppercorn
The American Journal of Gastroenterology|July 4, 2002
Equimolar doses of balsalazide and mesalamine: are we comparing apples and oranges?Richard J Farrell, Mark A Peppercorn
The American Journal of Managed Care|September 9, 2004
Inflammatory bowel diseaseNoel B Martins, Mark A Peppercorn
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Clinical Gastroenterology|April 30, 2004
The overlap of inflammatory bowel disease and diverticular diseaseMark A Peppercorn
Gastroenterology Clinics of North America|July 19, 2002
Inflammatory bowel disease. Medical therapy of specific clinical presentationsSubhas Banerjee, Mark A Peppercorn
Inflammatory Bowel Diseases|May 5, 2011
New genetic data support an association between celiac disease and inflammatory bowel diseaseGarrett Lawlor, Mark A Peppercorn
Therapeutic Advances in Gastroenterology|December 25, 2010
Ulcerative colitis: current treatment strategies and future prospectsSagar Garud, Mark A Peppercorn
World Journal of Gastroenterology|April 4, 2014
Immunosuppressive therapies for inflammatory bowel diseaseTalia Zenlea, Mark A Peppercorn
Clinical and Experimental Gastroenterology|June 23, 2011
Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's diseaseGlen A Doherty, Mark A Peppercorn
Lancet (London, England)|February 7, 2002
Ulcerative colitisRichard J Farrell, Mark A Peppercorn
Patient Preference and Adherence|November 26, 2009
Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamineDaniel B Zandman, Mark A Peppercorn
The American Journal of Gastroenterology|July 4, 2002
Equimolar doses of balsalazide and mesalamine: are we comparing apples and oranges?Richard J Farrell, Mark A Peppercorn
The American Journal of Managed Care|September 9, 2004
Inflammatory bowel diseaseNoel B Martins, Mark A Peppercorn
Pageof 3